-Reuters
Enlivex Announces Tislelizumab Clinical Collaboration, FY22 Financial Results, And Provides Business Updates; As Of December 31, 2022, Enlivex Had Cash, Cash Equivalents, Short Term Deposits Of $50.2M
Clinical collaboration with BeiGene announced on April 3, 2023 to evaluate the safety and efficacy of Allocetra™, an investigational macrophage-reprogramming cell therapy, in combination with